Clinical Trial Update: Feasibility Study to Estimate Number of Patients With Precancerous Areas in Their Airways and the Response to Gefitinib [Phase 2]

View source ↗

Summary

A Phase 2 feasibility trial to estimate the number of patients with precancerous airway areas and to assess their response to gefitinib; the study was terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Lung Cancer

Drugs mentioned

• Gefitinib (Gefitinib)

Snippet

Sponsor: Papworth Hospital NHS Foundation Trust | Conditions: Lung Cancer, Head and Neck Cancer | Phase 2 | Status: TERMINATED